Year : 2021 | Volume
| Issue : 2 | Page : 93-96
Spontaneous pneumomediastinum and subcutaneous emphysema in patients with COVID-19
Reema Wadhawa1, Avani Thakkar1, Heena Sunil Chhanwal1, Anju Bhalotra2, Yashpal Rana3, Vivek Wadhawa4
1 Department of Anesthesia, GCS Medical College, Hospital and Research Centre, Ahmedabad, Gujarat, India
2 Department of Anesthesia, Maulana Azad Medical College, Asarwa, Ahmedabad, Gujarat, India
3 Department of Radiology, U.N. Mehta Institute of Cardiology and Research Center, Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India
4 Department of Cardio Vascular and Thoracic Surgery, U.N. Mehta Institute of Cardiology and Research Center, Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India
Department of Anesthesia, GCS Medical College, Hospital & Research Centre, Opp. D.R.M. Office, Ahmedabad - 380 025, Gujarat
Source of Support: None, Conflict of Interest: None
|Date of Submission||11-Sep-2020|
|Date of Decision||20-Sep-2020|
|Date of Acceptance||29-Sep-2020|
|Date of Web Publication||01-Apr-2021|
Background: Coronavirus disease 2019 is an infectious disease caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-COV-2). Many aspects of its pathology and pathogenesis are not well understood.
Material and Methods: We describe a series of spontaneous air leak cases we found in our coronavirus disease 2019 (COVID-19) positive 1086-patient cohort.
Results: Two out of six patients eventually required mechanical ventilation and succumbed to COVID-19. We presume that acute lung injury leading to SARS-CoV-2 with associated acute respiratory distress syndrome predisposes patients to this complication.
Conclusion: This series is presented to highlight the emerging association of COVID-19 with spontaneous air leaks leading to pneumomediastinum, pneumothorax, and subsequent subcutaneous emphysema even in patients who have never received invasive mechanical ventilation and this may be more likely with the institution of high flow nasal cannula.
Keywords: ARDS; COVID -19; SARS-COV-2
|How to cite this article:|
Wadhawa R, Thakkar A, Chhanwal HS, Bhalotra A, Rana Y, Wadhawa V. Spontaneous pneumomediastinum and subcutaneous emphysema in patients with COVID-19. Saudi J Anaesth 2021;15:93-6
|How to cite this URL:|
Wadhawa R, Thakkar A, Chhanwal HS, Bhalotra A, Rana Y, Wadhawa V. Spontaneous pneumomediastinum and subcutaneous emphysema in patients with COVID-19. Saudi J Anaesth [serial online] 2021 [cited 2023 Jan 28];15:93-6. Available from: https://www.saudija.org/text.asp?2021/15/2/93/312973
| Introduction|| |
Coronavirus disease 2019 is an infectious disease caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-COV-2). The disease has caused significant morbidity and mortality across the world. This disease mainly affects the lungs and common findings include fever, cough, shortnesss of breath. While it is known that forceful coughing may lead to spontaneous pneumothorax in COPD patients, in our series, only one patient was a known case of COPD and five out of six patients had no prior pulmonary disease. Oxygen therapy is the mainstay of treatment and may be given via oxygen mask, noninvasive ventilation including use of high flow nasal cannula (HFNC), bilevel positive airway pressure (BIPAP), and in severe cases via invasive ventilation. According to WHO guidelines statement, the use of HFNC is placed prior to intubation and invasive ventilation in the overall plan of Covid-19 management. Similarly, the surviving sepsis guidelines of Society of Critical Care Medicine recommends the use of HFNC when conventional oxygen therapy fails and preferentially over noninvasive ventilation. Computed tomography (CT) has an important role in the evaluation and follows up of Covid-19 patients. We present a series of cases that developed subcutaneous emphysema and pneumothorax accompanying Covid-19 pneumonia after institution of HFNC.
| Materials and Methods|| |
In our hospital cared for 1086 coronavirus disease 2019 or COVID-19 (SARS-CoV-2), patients between April 1 and August 15, 2020. Out of these, six cases developed spontaneous air leak. One patient developed pneumomediastinum, three patients developed surgical emphysema along with pneumomediastinum and two developed an isolated pneumothorax. All the case files of patients with spontaneous air leak were retrospectively reviewed. All the data was analyzed.
| Results|| |
The demographic, clinical, laboratory, and imaging data of the six patients who developed a spontaneous air leak are provided in [Table 1]. The first patient was a 35-year-old nonsmoker obese (BMI 31) male with no other comorbidities, presented with fever. He was hemodynamically stable but with mild hypoxemia, COVID-19 positive by RTPCR and had elevated inflammatory markers. Gradually his hypoxemia worsened requiring HFNC at 40 L/min with FiO2 80% on the 9th day of symptom onset. On the 10th day of symptom onset, he developed subcutaneous emphysema over his neck. CT scan showed changes consistent with acute respiratory distress syndrome (ARDS) plus pneumomediastinum with subcutaneous emphysema extending into the neck [Figure 1]. HFNC was continued and weaned over 5 days with clinical improvement. Successive CT scans showed a resolution of pneumomediastinum without any surgical intervention [Figure 1].
|Figure 1: (a) Normal, axial image; (b) normal, coronal image; (c) mild covid, axial image, no pneumomediastinum; (d) mild covid, axial image, no pneumomediastinum; (e) coronalimage, pneumomediastinum; (f) axialimage, pneumomediastinum, minimal right pneumothorax; (g) coronal image, pneumomediastinum; (h) coronal image, minimal residual pneumomediastinum; (i) axial image, minimal residual pneumomediastinum; (j) coronal image, very minimal residual pneumomediastinum; and (k) axial image, very minimal residual pneumomediastinum|
Click here to view
|Table 1: Demographic, laboratory, and radiological data for six COVID-19 patients with spontaneous air leak|
Click here to view
The second patient was an 80-year-old male patient with the known history of hypertension. He was a nonsmoker admitted with complaint of shortness of breath and had an oxygen saturation of 83% on room air and 95% on oxygen with nonrebreathing mask. After a day of admission, his work of breathing increased and he was put on HFNC with FiO2 70% and flow of 30 L/min. The next day, he developed surgical emphysema extending to the neck and pneumomediastinum with mild pneumothorax. He was gradually weaned off HFNC over 2 days. No surgical intervention was required.
Another 65-year-old male patient with history of chronic smoking with emphysematous lung changes on chest X-ray was admitted with severe cough and high-grade fever. His oxygen requirement increased and was put on HFNC with Fio2 90% and flow rate 50 L/min. After 4 days of HFNC ventilation, chest X-ray revealed a right-sided pneumothorax and an intercostal drain (ICD) was inserted. However the patient's condition continued to deteriorate and he required endotracheal intubation and invasive ventilation. He eventually succumbed to the disease.
A 26-year-old female patient with fever and severe cough without any history of smoking developed left spontaneous pneumothorax. A left ICD was inserted. The patient recovered well without any ventilator support.
A 45-year-old female put on HFNC in view of respiratory distress developed pneumomediastinum and surgical emphysema. She subsequently required endotracheal intubation and invasive ventilation and eventually succumbed.
A 29-year-old male patient admitted with cough and fever. He required HFNC on the 10th day of his symptoms onset. The patient improved well on HFNC and weaned off gradually on the second day; his chest X-ray suggested of pneumomediastinum. He remained asymptomatic n recovered well.
| Discussion|| |
Air leak is a well-known complication of positive pressure ventilation. HFNC provides increased positive pressure within the airways, which may potentially cause air leak. Radiological evidence of spontaneous air leak was found in six patients with event onset 10.33 ± 1.86 days (mean ± SD) from COVID-19 symptom onset. Two out of six patients required intubation, but all pneumomediastinum/pneumothorax events occurred before intubation. No difference in age, gender, body mass index, or medical histories as compared to other COVID-19 patients was noted except for one out of six patients having an obstructive lung disease. Two out of the six patients expired.
COVID-19 infection leading to acute lung injury with associated ARDS might be associated with a spontaneous air leak. Spontaneous air leak occurs due to leakage of air from ruptured alveoli via peribronchovascular sheaths into the mediastinum, the pleural space, or the subcutaneous tissue. It can occur in the setting of obstructive or restrictive lung disease exacerbation, although it has been observed in hyperventilation states such as infections, vomiting, diabetic ketoacidosis, athletic activities, or inhalational drug abuse. Air leak in hospitalized SARS-CoV-2 patients has been sparsely published as case reports. As a result of the diffuse alveolar injury in severe COVID-19 pneumonia, the alveoli may be fragile and prone to rupture. If a patient should have a severe cough, this may also further induce alveolar rupture.
In a similar way, if a patient is receiving positive pressure oxygen therapy in the form of HFNC or BIPAP, which are used to improve oxygenation and alleviate the respiratory distress in these patients, the chances of air leaks should be proportionally increased. Other authors too have suggested that the alveoli of COVID-19 patients may be prone to rupture due to diffuse alveolar injury caused by SARS-CoV-2.
This tendency to develop spontaneous pneumothorax may be higher in patients with COPD due to the long-term increase of alveolar pressure, decrease of alveolar capillary blood supply, and poor lung tissue nutrition in COPD, leading to reduced elasticity and tolerance of the alveolar walls. Pneumomediastinum unrelated to mechanical ventilation has been reported in COVID-19 and severe acute respiratory syndrome (SARS)., Chu et al. reported that in SARS, mean presentation of pneumomediastinum was 19.6 days post symptom onset. These complications may result in sudden clinical deterioration and oxygen desaturation late in the course of covid pneumonia. Clinicians managing these patients should be alert to the possibility of these complications, and these must be kept in mind in case of any sudden clinical deterioration.
| Conclusions|| |
This case series highlights the emerging association of COVID-19 with pneumomediastinum and pneumothorax and the need to be alert to this complication even in patients who never received mechanical ventilation or positive airway pressure support. Any acute deterioration with rapid oxygen desaturation in a COVID-19 patient could indicate pneumothorax or pneumomediastinum. Many of these cases have developed after the use of positive pressure ventilation in the form of NIV or HFNC or intubation., Thus, all clinicians should be aware of these complications in patients with covid pneumonia. Further research is needed into the exact pathogenesis and prevalence of this complication.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance, 13 March 2020. World Health Organization; 2020.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al
. Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
Chu CM, Leung YY, Hui JY, Hung IF, Chan VL, Leung WS, et al
. Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur Respir J 2004;23:802-4.
Iyer VN, Joshi AY, Ryu JH. Spontaneous pneumomediastinum: Analysis of 62 consecutive adult patients. Mayo Clin Proc 2009;84:417-21.
Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020;21:541-4.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al
. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2.
Gadre SK, Duggal A, Mireles-Cabodevila E, Krishnan S, Wang XF, Zell K, et al
. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD). Medicine (Baltimore) 2018;97:e0487. doi: 10.1097/MD.0000000000010487.
Zhou C, Gao C, Xie Y, Xu M. COVID-19 with spontaneous pneumomediastinum. Lancet Infect Dis 2020;20:510.
Wang J, Su X, Zhang T, Zheng C. Spontaneous pneumomediastinum: A probable unusual complication of coronavirus disease 2019 (COVID-19) pneumonia. Korean J Radiol 2020;21:627-8.
Chan MS, Chan IY, Fung KH, Poon E, Yam LY, Lau KY. High-resolution CT findings in patients with severe acute respiratory syndrome: A pattern-based approach. Am J Roentgenol 2004;182:49-56.
|This article has been cited by|
||Clinical observation of pneumomediastinum in a case of severe COVID-19-associated pneumonia in a teenager
| ||E. V. Knizhnikova, G. P. Evseeva, S. A. Cherezov, T. M. Adlivankina, R. S. Telepneva, S. V. Suprun, O. A. Lebedko |
| ||Bulletin Physiology and Pathology of Respiration. 2022; (85): 108 |
|[Pubmed] | [DOI]|
||Pneumomediastinum in the COVID-19 era: to drain or not to drain?
| ||Nian Patel, Robert Nicolae, Georgios Geropoulos, Pallabhi Mandal, Chrysanthos D. Christou, Marianna Gavala, Nikolaos Madouros, Michail Papapanou, Rahul Mogal, Dimitrios Giannis, Konstantinos S. Kechagias, Nikolaos Panagiotopoulos |
| ||Monaldi Archives for Chest Disease. 2022; |
|[Pubmed] | [DOI]|
||Air leak syndromes (Pneumomediastinum, pneumothorax, and subcutaneous emphysema) in critically ill COVID-19 patients – Prevalence, risk factors, and outcome
| ||Parth Sharma, Rakesh Mohanty, Preethi Kurian, David Vincent, Aditi Dadsena, Manisha Mane, Sankara Narayanan, Sheetal Babu, PritishJohn Korula |
| ||Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2022; 0(0): 0 |
|[Pubmed] | [DOI]|
||Air leaks in COVID-19
| ||Deven Juneja, Sahil Kataria, Omender Singh |
| ||World Journal of Virology. 2022; 11(4): 176 |
|[Pubmed] | [DOI]|